FINE-NEEDLE ASPIRATION CYTOLOGY OF RECURRENT AND METASTATIC MIXED MESODERMAL TUMORS

被引:5
作者
MOURAD, WA
SNEIGE, N
KATZ, RL
CARAWAY, NP
FANNING, TV
机构
[1] University of Texas M.D. Anderson Cancer Center, Houston, Texas
[2] University of Alberta Hospitals, Edmonton, Alberta
关键词
MALIGNANT MIXED MESODERMAL TUMOR; FINE-NEEDLE ASPIRATION; RECURRENCE; METASTASIS;
D O I
10.1002/dc.2840110404
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
We report the cytological and clinical findings of 16 fine-needle aspirates (FNAs) performed on recurrent (n = 6) and metastatic (n = 10) mixed mesodermal tumors (MMMTs), The median interval between the primary diagnosis and FNA was 16 mo. Primary sites were the endometrium (n = 11), the ovary (n = 3), the cervix (n = 1), and pelvic soft tissue (n = 1). Primary tumors showed carcinoma with homologous mesenchymal components in 13 cases and focal heterologous elements in three (two chondrosarcomas and one rhabdomyosarcoma). The FNAs showed carcinoma in all 16 cases, with adenocarcinoma differentiation in three. Mesenchymal elements were identified in aspirates of three recurrent and two metastatic lesions. They were all homologous. No heterologous mesenchymal elements were identified in the aspirates. We conclude that mesenchymal components in FNAs of MMMTs are less likely to be seen in metastatic lesions, and that heterologous mesenchymal components are rarely seen in these aspirates even in recurrent disease. These findings confirm that the epithelial component is responsible for the malignant behavior of MMMTs, and suggest that these lesions may need to be classified as sarcomatoid carcinomas rather than true carcinosarcomas. (C) 1994 Wiley-Liss, Inc.
引用
收藏
页码:328 / 332
页数:5
相关论文
共 19 条
  • [1] Marchese MJ, Liskow AS, Crum CP, Et al., Uterine sarcomas: a clinicopathologic study, 1965–1981, Gynecol Oncol, 18, pp. 299-312, (1984)
  • [2] Macasaet MA, Waxman M, Fruchter RG, Et al., Prognostic factors in malignant mesodermal (Mulierian) mixed tumors of the uterus, Gynecol Oncol, 20, (1985)
  • [3] De Brito PA, Silverberg SG, Orenstein JM, pp. 132-142, (1993)
  • [4] Muntz HG, Rutgers JL, Tanaza HM, Fuller AF, Carcinosarcoma and mesodermal mixed tumors of the fallopian tube, Gynecol Oncol, 34, pp. 109-115, (1989)
  • [5] Kinoshita M, Asano S, Yamashita M, Matsuda T., Mesodermal mixed tumors primary in the fallopian tube, Gynecol Oncol, 32, pp. 331-335, (1989)
  • [6] Aurebach HE, Livolsi VA, Merino MJ, Malignant mixed Müllerian tumors of the uterus. An immunohistochemical study, International Journal of Gynecological Pathology, 7, pp. 123-130, (1988)
  • [7] Barwick KW, Livolsi VA, Malignant mixed Müllerian tumors of the uterus. A clinico‐pathological assessment of 34 cases, Am J Surg Pathol, 3, pp. 125-135, (1979)
  • [8] Geisinger KR, Dabbs DJ, Marshall RB, Malignant mixed Müllerian tumors. An ultrastructural and immunohistochemical analysis with histogenetic considerations, Cancer, 59, pp. 1781-1790, (1987)
  • [9] Ramadan M, Gondie RB, Epithelial antigens in malignant mixed mesodermal tumors of endometrium, J Pathol, 148, pp. 13-18, (1986)
  • [10] Shaw RW, Lynch PF, Wade-Evans T., Müllerian mixed tumours of the uterine corpus: a clinical histopathological review of 28 patients, Br J Obstet Gynaecol, 90, pp. 562-569, (1983)